openPR Logo
Press release

Turkey Pharmaceutical Market Set to Reach $12.23 Billion by 2032, Growing at a 4.50% CAGR

09-24-2024 11:56 AM CET | Health & Medicine

Press release from: IMARC Group

Turkey Pharmaceutical Market Set to Reach $12.23 Billion

According to the latest report by IMARC Group, titled "๐“๐ฎ๐ซ๐ค๐ž๐ฒ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž (๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ, ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ), ๐๐š๐ญ๐ฎ๐ซ๐ž (๐Ž๐ซ๐ ๐š๐ง๐ข๐œ, ๐‚๐จ๐ง๐ฏ๐ž๐ง๐ญ๐ข๐จ๐ง๐š๐ฅ), ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ," the report presents a thorough review featuring the Turkey Pharmaceutical Market growth, share, trends, and research of the industry.

The Turkey pharmaceutical market size reached US$ 7.81 Billion in 2023. Looking forward, IMARC Group expects the market to reach ๐”๐’$ ๐Ÿ๐Ÿ.๐Ÿ๐Ÿ‘ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2032, exhibiting a growth rate (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ’.๐Ÿ“๐ŸŽ% during 2024-2032.

The Turkey pharmaceutical market is expanding rapidly, owing to several interconnected factors. Primarily, the developing healthcare industry and expanding population of the country are the main drivers of the market, driving up demand for pharmaceuticals and other healthcare supplies. Besides this, the focus of the government bodies on expanding healthcare accessibility and infrastructure is one of the main forces behind the increase in regional pharmaceutical investment and manufacturing.

In line with these factors, the rising incidences of chronic diseases such as diabetes, cardiovascular disorders, and cancer are further fueling the need for affordable and effective pharmaceutical solutions, driving the growth of the Turkey pharmaceutical market. Additionally, Turkey is also becoming a hub for generic drug manufacturing, catering to both domestic and international markets.

๐…๐จ๐ซ ๐š๐ง ๐ข๐ง-๐๐ž๐ฉ๐ญ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ, ๐˜๐จ๐ฎ ๐‚๐š๐ง ๐‘๐ž๐Ÿ๐ž๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.imarcgroup.com/turkey-pharmaceutical-market/requestsample

๐“๐ฎ๐ซ๐ค๐ž๐ฒ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ & ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

The increasing focus on research and development (R&D) and innovation is the major factor propelling the growth of the Turkey pharmaceutical market. Moreover, local and international companies are investing heavily in the development of biologics, biosimilars, and specialty medicines to address complex health conditions. In addition to these factors, the market is also witnessing a shift towards digital healthcare solutions and e-pharmacies, making medicines highly accessible.

Furthermore, with Turkey's strategic location, the country is emerging as a key player in pharmaceutical exports, particularly to Europe, the Middle East, and Africa. These factors, along with government initiatives supporting domestic pharmaceutical production, are expected to drive the growth of the Turkey pharmaceutical market in the coming years.

๐“๐ฎ๐ซ๐ค๐ž๐ฒ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

The report provides an analysis of the key trends in each segment of the market, along with forecasts at the country levels for 2024-2032. The market has categorized based on type and nature.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

โ€ข Pharmaceutical Drugs
o Cardiovascular Drugs
o Dermatology Drugs
o Gastrointestinal Drugs
o Genito-Urinary Drugs
o Hematology Drugs
o Anti-Infective Drugs
o Metabolic Disorder Drugs
o Musculoskeletal Disorder Drugs
o Central Nervous System Drugs
o Oncology Drugs
o Ophthalmology Drugs
o Respiratory Diseases Drugs
โ€ข Biologics
o Monoclonal Antibodies (MAbS)
o Therapeutic Proteins
o Vaccines

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐๐š๐ญ๐ฎ๐ซ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

โ€ข Organic
โ€ข Conventional

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:

โ€ข Marmara
โ€ข Central Anatolia
โ€ข Mediterranean
โ€ข Aegean
โ€ข Southeastern Anatolia
โ€ข Blacksea
โ€ข Eastern Anatolia

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

๐’๐ฉ๐ž๐š๐ค ๐ญ๐จ ๐š๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐จ๐ซ ๐€๐ง๐ฒ ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ฒ๐ข๐ง๐  ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.imarcgroup.com/request?type=report&id=24198&flag=C

๐Š๐ž๐ฒ ๐ก๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

โ€ข COVID-19 Impact on the Market
โ€ข Porter's Five Forces Analysis
โ€ข Strategic Recommendations
โ€ข Market Dynamics
โ€ข Historical, Current and Future Market Trends
โ€ข Market Drivers and Success Factors
โ€ข SWOT Analysis
โ€ข Value Chain Analysis
โ€ข Comprehensive Mapping of the Competitive Landscape
โ€ข Top Winning Strategies
โ€ข Recent Industry News
โ€ข Key Technological Trends & Development

๐๐จ๐ญ๐ž: ๐ˆ๐Ÿ ๐ฒ๐จ๐ฎ ๐ง๐ž๐ž๐ ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐ญ๐ก๐š๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฐ๐ข๐ญ๐ก๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐œ๐จ๐ฉ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ฐ๐ž ๐œ๐š๐ง ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž ๐ข๐ญ ๐ญ๐จ ๐ฒ๐จ๐ฎ ๐š๐ฌ ๐š ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

๐ˆ๐Œ๐€๐‘๐‚ ๐†๐ซ๐จ๐ฎ๐ฉ
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 | Americas: +1 631 791 1145

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Turkey Pharmaceutical Market Set to Reach $12.23 Billion by 2032, Growing at a 4.50% CAGR here

News-ID: 3665631 • Views: โ€ฆ

More Releases from IMARC Group

Brewery Consulting Business Setup Guide: Revenue Model, Cost Analysis & Market Insights 2025
Brewery Consulting Business Setup Guide: Revenue Model, Cost Analysis & Market I โ€ฆ
Overview: IMARC Group's "Brewery Consulting Business Plan and Project Report 2025" provides a detailed and data-driven roadmap for establishing and operating a successful brewery consulting business. The report highlights industry performance, key market trends, operational models, investment needs, and profitability forecasts. It serves as a valuable resource for entrepreneurs, investors, consultants, and business strategists. It also offers comprehensive guidance on Brewery Consulting Business setup, covering infrastructure planning, service offerings, resource allocation,โ€ฆ
Xenon Prices, Latest Trend, Demand, Index & Uses 2025
Xenon Prices, Latest Trend, Demand, Index & Uses 2025
North America Xenon Prices Movement Q2: Xenon Prices in USA: During the second quarter of 2025, Xenon Prices in the USA reached 2,966 USD/MT in June. Prices remained elevated due to restricted output from air separation units and steady demand from the semiconductor and medical imaging industries. Heavy reliance on imports added cost pressures, with logistics and procurement challenges further influencing final market prices. The supply environment stayed tight, with minimal freshโ€ฆ
Philippines Potato Chips Market Size Worth USD 233.12 Million From 2025 to 2033
Philippines Potato Chips Market Size Worth USD 233.12 Million From 2025 to 2033
Market Overview The Philippines potato chips market reached a market size of USD 158.40 Million in 2024. It is expected to grow to USD 233.12 Million by 2033, driven by factors such as rising premium snack demand, international brand presence, and expanding retail and e-commerce networks. These trends are improving product innovation and accessibility, broadening consumer options and frequency of purchase. The forecast period for this market is 2025-2033, with aโ€ฆ
Philippines Banking Market 2026 | Projected to Reach USD 62.6 Billion by 2034 | At a 22.07% CAGR
Philippines Banking Market 2026 | Projected to Reach USD 62.6 Billion by 2034 | โ€ฆ
Market Overview The Philippines banking market reached a size of USD 10.4 Billion in 2025 and is projected to expand to USD 62.6 Billion by 2034, exhibiting a growth of 22.07% CAGR. This growth is supported by rising financial inclusion, a growing middle class, and strong remittance inflows that boost household finances. Innovations in digital banking and fintech, supported by government policies promoting financial inclusion and cashless transactions, are transforming theโ€ฆ

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant โ€ฆ
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the brandedโ€ฆ
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcoholโ€ฆ
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob โ€ฆ
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venousโ€ฆ
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re โ€ฆ
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplicationโ€ฆ
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastestโ€ฆ
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patientโ€™s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$โ€ฆ